Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: Relevance to Parkinson's disease

Journal of Neurochemistry

Volumn 63, Issue 5, 1994, Pages 1987-1990

  Hartley, A ^a   Stone, J M ^a   Heron, C ^a   Cooper, J M ^a   Schapira, A H V ^a,b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

1 Methyl 4 phenylpyridinium; Apoptosis; Complex I; Mitochondria; Parkinson's disease

Indexed keywords

2,3 DIHYDRO 1 METHYL 4 PHENYLPYRIDINIUM; ENZYME INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE;

APOPTOSIS; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; ETIOLOGY; HUMAN; HUMAN CELL; NERVE CELL GROWTH; PARKINSON DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; SUBSTANTIA NIGRA;

EID: 84975751684     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1994.63051987.x     Document Type: Article

References (23)

1. Calne D. B. (1992) The free radical hypothesis in idiopathic parkinsonism: evidence against it. Ann. Neurol. 32, 799-803.
2. Chiueh C. C., Huang S.-J., and Murphy D. L. (1992) Enhanced hydroxyl radical generation by 2′methyl analogue of MPTP: suppression by clorgyline and deovenyl. Synapse 11, 346-348.
3. Clark J. B. and Nicklas W. J. (1970) The metabolism of rat brain mitochondrial preparations and characterisation. J. Biol. Chem. 245, 4724-4731.
4. Cleeter M. J. W., Cooper J. M., and Schapira A. H. V. (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl 4-phenylpyridinium: evidence for free radical involvement. J. Neurochem. 58, 786-789.
5. Dexter D. T., Carayon A., Vidailhet M., Ruberg M., Agid F., Agid Y., Lees A. J., Wells F. R., Jenner P., and Marsden C. D. (1990) Decreased ferritin levels in brain in Parkinson's disease. J. Neurochem. 55, 16-20.
6. Dipasquale B., Marini A. M., and Youie R. J. (1991) Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem. Biophys. Res. Commun. 181, 1442-1448.
7. Fahn S. and Cohen G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804-812.
8. Harris D. A. (1987) Spectrophotometric assays, in Spectrophotometry and Spectrofluorimetry: A Practical Approach (Harris D. A. and Bashford C. L., eds), pp. 49-90. IRL Press, Oxford.
9. Hartley A., Cooper J. M., and Schapira A. H. V. (1993) Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease. Brain Res. 627, 349-353.
10. +) induces NADH dependent superoxide formation and enhances NADH-dependent lipid peroxidation in beef heart submitochondrial particles. Biochem. Biophys. Res. Commun. 170, 1049-1055.
11. Hockenbery D. M., Oltvai Z. N., Yin X.-M., Milliman C. L., and Korsmeyer S. J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
12. Jacobsen M. D., Burne J. F., King M. P., Miyashita T., Reed J. C., and Raff M. C. (1993) Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361, 365-369.
13. Janetzsky B., Hauck S., Youdim M. B. H., Riederer P., Jellinger K., Pantucek F., Zochling R., Boissl K. W., and Reichmann H. (1994) Unaltered aconitase activity but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett. 169, 126-128.
14. Jenner P., Schapira A. H. V., and Marsden C. D. (1992) New insights into the cause of Parkinson's disease. Neurology 42, 2241-2250.
15. Labarca C. and Paigen K. (1980) A simple, rapid and sensitive DNA assay precedure. Anal. Biochem. 102, 344-352.
16. Lai M., Griffiths H., Pall H., Williams A., and Lunec J. (1993) An investigation into the role of reactive oxygen species in the mechanism of l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity using neuronal cell lines. Biochem. Pharmacol. 45, 927-933.
17. Old J. M. (1986) Fetal DNA analysis, in Human Genetic Diseases: A Practical Approach (Davies K. E., ed), pp. 1-17. IRL Press, Oxford.
18. Schapira A. H. V. (1994) Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal. Mov. Disord. 9, 125-138.
19. Schapira A. H. V., Cooper J. M., Dexter D., Clark J. B., Jenner P., and Marsden C. D. (1990) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54, 823-827.
20. Sellins K. S. and Cohen J. J. (1987) Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139, 3199-3206.
21. Singer T. P. and Ramsay R. R. (1990) Biochemical reactions leading to parkinsonian symptoms elicited by MPTP, in Basic, Clinical and Therapeutic Aspects of Alzheimer's and Parkinson's Disease (Nagatsu T., Fisher A., and Yoshida M., eds), pp. 219-225. Plenum Press, New York.
22. Takeshige K. and Minikami S. (1979) NADH and NADPH dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH ubiquinone reductase preparation. Biochem. J. 180, 129-135.
23. Wolvetang E. J., Johnson K. L., Krauer K., Ralph S. J., and Linnane A. W. (1994) Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett. 339, 40-44.